)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
JB Chemicals & Pharmaceuticals (506943) investor relations material
JB Chemicals & Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary31 Jul, 2025
Executive summary
Torrent Pharma announced acquisition of a 46.39% stake in JB Pharma for INR 11,917 crores, triggering a mandatory tender offer and planned merger, subject to regulatory approvals.
Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, with limited review by statutory auditors.
Business operations remain strong, with JB Pharma among the fastest growing in the Indian pharma market and maintaining focus on top-line momentum and cost optimization.
Domestic business grew 14% YoY, maintaining fastest growth among top 25 pharma companies in India.
Major corporate event: Share purchase agreement with Torrent Pharmaceuticals, leading to a change in promoter and planned amalgamation.
Financial highlights
Q1 FY26 revenues rose 9% year-over-year to INR 1,094 crores; domestic business grew 14% to INR 678 crores, international business up 2%.
Operating EBITDA (excluding non-cash ESOP and one-off merger charges) increased 13% to INR 330 crores; net profit up 14% to INR 202 crores.
Gross margin improved to 68.3% (up 210 bps year-over-year); operating EBITDA margin reached 30.2% (up 120 bps).
Consolidated revenue from operations reached ₹109,394 lakhs, up from ₹100,440 lakhs year-over-year; consolidated net profit after tax was ₹20,238 lakhs, compared to ₹17,683 lakhs in the same quarter last year.
Employee benefit and other expenses rose 16% YoY, partly due to ESOP and one-off merger charges.
Outlook and guidance
Domestic business expected to grow 12–14% for the year, outperforming market by 300–350 bps; market growth forecasted at 8–10%.
CDMO segment guided to grow 12–14% for the year, with H1 run rate at INR 120 crores and H2 at INR 130 crores.
Operating EBITDA margin guidance maintained at 27–29% for the full year; gross margin guidance at 67%.
Board and acquirer approved a scheme of amalgamation, with a share swap ratio of 51:100 (Acquirer:Company), subject to statutory approvals.
Open offer announced for public shareholders as part of the acquisition process.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next JB Chemicals & Pharmaceuticals earnings date
Q2 25/266 Nov, 2025
Next JB Chemicals & Pharmaceuticals earnings date
Q2 25/266 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
JB Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of branded and generic formulations, as well as active pharmaceutical ingredients. The company’s product portfolio spans therapeutic areas such as cardiovascular, gastrointestinal, anti-infective, and pain management. It operates manufacturing facilities approved by international regulatory agencies and supplies products to both domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage